Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2021-10-15

First-in-class medicine to treat aggressive form of breast cancer

View source ↗

Summary

EMA announces a first-in-class medicine approved to treat an aggressive form of breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications